Stock Comparison
JNJ vs NVS
Johnson & Johnson and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$626.01B
$287.36B
P/E (TTM)
30.1
22.9
Forward P/E
22.3
16.9
Price/Sales
6.4
5.1
Price/Book
7.4
6.9
EV/EBITDA
19.3
14.5
Dividend Yield
2.00%
3.15%
Profitability
Net Margin
21.83%
24.14%
Operating Margin
26.87%
30.54%
Return on Equity
25.70%
30.30%
Return on Assets
8.60%
10.20%
Growth (YoY)
Revenue Growth
6.60%
0.80%
Earnings Growth
-0.90%
-17.00%
Price & Risk
Beta
0.2
0.5
52-Week High
$267.34
$163.61
52-Week Low
$170.46
$118.18
Analyst Target
$272.50
$155.37
Compare JNJ and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.